Biguanides enhance antifungal activity against Candida glabrata

Candida spp. are the fourth leading cause of nosocomial blood stream infections in North America. Candida glabrata is the second most frequently isolated species, and rapid development of antifungal resistance has made treatment a challenge. In this study, we investigate the therapeutic potential of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shuying Xu, Marianela Feliu, Allison K. Lord, Daniel P. Lukason, Paige E. Negoro, Nida S. Khan, Zeina Dagher, Michael B. Feldman, Jennifer L. Reedy, Samantha N. Steiger, Jenny M. Tam, Alexander A. Soukas, David B. Sykes, Michael K. Mansour
Formato: Artigo
Lenguaje:Inglês
Publicado: Taylor & Francis Group 2018-12-01
Colección:Virulence
Materias:
Candida
Candida glabrata
biguanide
drug resistance
metformin
minimum inhibitory concentration (MIC)
Acceso en línea:http://dx.doi.org/10.1080/21505594.2018.1475798
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares